Marco Righetti

2.0k total citations
34 papers, 1.1k citations indexed

About

Marco Righetti is a scholar working on Nephrology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Righetti has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 8 papers in Rheumatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Righetti's work include Dialysis and Renal Disease Management (7 papers), Folate and B Vitamins Research (7 papers) and Complementary and Alternative Medicine Studies (4 papers). Marco Righetti is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Folate and B Vitamins Research (7 papers) and Complementary and Alternative Medicine Studies (4 papers). Marco Righetti collaborates with scholars based in Italy, Germany and Switzerland. Marco Righetti's co-authors include Giuseppe Bianchi, Cristina Barlassina, Daniele Cusi, Paola Stella, Chiara Lanzani, Giorgio Casari, Lorena Citterio, Rodolfo Rivera, Paolo Manunta and Laura Zagato and has published in prestigious journals such as The Lancet, Kidney International and Hypertension.

In The Last Decade

Marco Righetti

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Righetti Italy 14 425 362 269 178 173 34 1.1k
Eke G. Gruppen Netherlands 22 549 1.3× 250 0.7× 454 1.7× 378 2.1× 111 0.6× 53 1.5k
Rosario Scaglione Italy 25 343 0.8× 864 2.4× 161 0.6× 405 2.3× 144 0.8× 78 1.7k
Ki‐Chul Sung South Korea 24 796 1.9× 412 1.1× 202 0.8× 281 1.6× 47 0.3× 44 1.8k
Yüksel Altuntaş Türkiye 22 518 1.2× 161 0.4× 185 0.7× 151 0.8× 47 0.3× 93 1.3k
Alberto Mazza Italy 24 404 1.0× 597 1.6× 128 0.5× 142 0.8× 48 0.3× 93 1.6k
Nigel Wheeldon United Kingdom 18 370 0.9× 1.1k 2.9× 142 0.5× 106 0.6× 56 0.3× 40 1.6k
Triantafyllos Didangelos Greece 24 674 1.6× 481 1.3× 204 0.8× 323 1.8× 58 0.3× 83 1.8k
Dalila B. Corry United States 16 373 0.9× 250 0.7× 297 1.1× 142 0.8× 100 0.6× 30 1.4k
Steven Joseph Haas Australia 13 151 0.4× 547 1.5× 322 1.2× 133 0.7× 66 0.4× 18 1.6k
Mika Enomoto Japan 21 368 0.9× 384 1.1× 197 0.7× 360 2.0× 36 0.2× 56 1.4k

Countries citing papers authored by Marco Righetti

Since Specialization
Citations

This map shows the geographic impact of Marco Righetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Righetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Righetti more than expected).

Fields of papers citing papers by Marco Righetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Righetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Righetti. The network helps show where Marco Righetti may publish in the future.

Co-authorship network of co-authors of Marco Righetti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Righetti. A scholar is included among the top collaborators of Marco Righetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Righetti. Marco Righetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Righetti, Marco, et al.. (2021). Supervised machine learning for the assessment of Chronic Kidney Disease advancement. Computer Methods and Programs in Biomedicine. 209. 106329–106329. 38 indexed citations
2.
Papo, David, Marco Righetti, Luciano Fadiga, Fabio Biscarini, & Massimiliano Zanin. (2020). A minimal model of hospital patients’ dynamics in COVID-19. Chaos Solitons & Fractals. 140. 110157–110157. 6 indexed citations
3.
Lesma, Elena, et al.. (2018). Tuberous sclerosis complex: new insights into clinical and therapeutic approach. Journal of Nephrology. 32(3). 355–363. 16 indexed citations
4.
Prearo, Marino, Marco Righetti, Laura Serracca, et al.. (2016). Fish doctor and beauty center: a possible marriage in respect of public health. European Journal of Public Health. 26(suppl_1). 1 indexed citations
5.
Righetti, Marco. (2012). Cardio-Renal-Anemia Syndrome: A Link Between Erythropoietin, Dimethylarginine and Homocysteine. Current Medicinal Chemistry. 19(21). 3502–3507. 4 indexed citations
6.
Righetti, Marco, et al.. (2010). An uncommon case of crowned dens syndrome in a dialysis patient. American Journal of Case Reports. 11. 29–31.
7.
Righetti, Marco. (2009). Protective Effect of Vitamin B Therapy on Bone and Cardiovascular Disease. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery). 4(1). 37–44. 6 indexed citations
8.
Righetti, Marco, et al.. (2008). Some Old Drugs Improve Late Primary Patency Rate of Native Arteriovenous Fistulas in Hemodialysis Patients. Annals of Vascular Surgery. 23(4). 491–497. 26 indexed citations
9.
Righetti, Marco. (2007). Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Clinical Chemistry and Laboratory Medicine (CCLM). 45(12). 1586–9. 20 indexed citations
10.
Bornhöft, Gudrun, Ursula Wolf, Klaus von Ammon, et al.. (2006). Effectiveness, Safety and Cost-Effectiveness of Homeopathy in General Practice – Summarized Health Technology Assessment. Complementary Medicine Research. 13(2). 19–29. 51 indexed citations
11.
Righetti, Marco, et al.. (2006). Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients. Blood Purification. 24(4). 379–386. 79 indexed citations
12.
Sessa, Adalberto, Graziana Battini, Mietta Meroni, et al.. (2005). Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: Identification of a new germline mutation. Journal of Nephrology. 18(2). 209–212. 3 indexed citations
13.
Sessa, Adalberto, Mietta Meroni, Graziana Battini, Marco Righetti, & Renzo Mignani. (2004). Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease. Seminars in Nephrology. 24(5). 532–536. 12 indexed citations
14.
Righetti, Marco, et al.. (2004). Effective Homocysteine-Lowering Vitamin B Treatment in Peritoneal Dialysis Patients. Peritoneal Dialysis International. 24(4). 373–377. 14 indexed citations
15.
Sessa, Adalberto, Marco Righetti, & Graziana Battini. (2004). Autosomal recessive and dominant polycystic kidney diseases.. PubMed. 56(4). 329–38. 12 indexed citations
16.
Sessa, Adalberto, Mietta Meroni, Graziana Battini, et al.. (2003). Evolution of renal pathology in Fabry disease. Acta Paediatrica. 92(s443). 6–8. 17 indexed citations
17.
Sessa, Adalberto, Mietta Meroni, Graziana Battini, et al.. (2003). Renal involvement in Anderson-Fabry disease. Journal of Nephrology. 16(2). 310–313. 28 indexed citations
18.
Sessa, Adalberto, et al.. (2001). Autosomal Recessive Polycystic Kidney Disease. Contributions to nephrology. 50–56. 9 indexed citations
19.
Manunta, Paolo, Daniele Cusi, Cristina Barlassina, et al.. (1998). α-Adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney International. 53(6). 1471–1478. 119 indexed citations
20.
Cusi, Daniele, Cristina Barlassina, Giorgio Casari, et al.. (1997). Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. The Lancet. 349(9062). 1353–1357. 417 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eke G. Gruppen Breakdown of academic impact, for papers by Rosario Scaglione Breakdown of academic impact, for papers by Ki‐Chul Sung Breakdown of academic impact, for papers by Yüksel Altuntaş Breakdown of academic impact, for papers by Alberto Mazza Breakdown of academic impact, for papers by Nigel Wheeldon Breakdown of academic impact, for papers by Triantafyllos Didangelos Breakdown of academic impact, for papers by Dalila B. Corry Breakdown of academic impact, for papers by Steven Joseph Haas Breakdown of academic impact, for papers by Mika Enomoto
Rankless by CCL
2026